StockNews.com Begins Coverage on Minerva Neurosciences (NASDAQ:NERV)
StockNews.com started coverage on shares of Minerva Neurosciences (NASDAQ:NERV – Free Report) in a research note released on Saturday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright lowered their price objective on shares of Minerva Neurosciences from $7.00 to $5.00 and set a “neutral” rating for the company […]
3 Nov 14:50 · The Markets Daily